dc.contributor.author |
Forster, Michael |
|
dc.contributor.author |
Gehringer, Matthias |
|
dc.contributor.author |
Pfaffenrot, Ellen |
|
dc.contributor.author |
Bauer, Silke Mona |
|
dc.contributor.author |
Laufer, Stefan |
|
dc.date.accessioned |
2018-12-04T13:19:47Z |
|
dc.date.available |
2018-12-04T13:19:47Z |
|
dc.date.issued |
2016 |
|
dc.identifier.issn |
1756-8927 |
|
dc.identifier.uri |
http://hdl.handle.net/10900/85164 |
|
dc.language.iso |
en |
de_DE |
dc.publisher |
Future Sci Ltd |
de_DE |
dc.relation.uri |
http://dx.doi.org/10.4155/fmc-2016-0132 |
de_DE |
dc.rights |
info:eu-repo/semantics/closedAccess |
|
dc.subject.ddc |
540 |
de_DE |
dc.title |
Tofacitinib and analogs as inhibitors of the histone kinase PRK1 (PKN1) |
de_DE |
dc.type |
Article |
de_DE |
utue.quellen.id |
20180405102126_01413 |
|
utue.publikation.seiten |
1537-1551 |
de_DE |
utue.personen.roh |
Ostrovskyi, Dmytro |
|
utue.personen.roh |
Rumpf, Tobias |
|
utue.personen.roh |
Eib, Julia |
|
utue.personen.roh |
Lumbroso, Alexandre |
|
utue.personen.roh |
Slynko, Inna |
|
utue.personen.roh |
Klaeger, Susan |
|
utue.personen.roh |
Heinzlmeir, Stephanie |
|
utue.personen.roh |
Forster, Michael |
|
utue.personen.roh |
Gehringer, Matthias |
|
utue.personen.roh |
Pfaffenrot, Ellen |
|
utue.personen.roh |
Bauer, Silke Mona |
|
utue.personen.roh |
Schmidtkunz, Karin |
|
utue.personen.roh |
Wenzler, Sandra |
|
utue.personen.roh |
Metzger, Eric |
|
utue.personen.roh |
Kuster, Bernhard |
|
utue.personen.roh |
Laufer, Stefan |
|
utue.personen.roh |
Sippl, Wolfgang |
|
utue.personen.roh |
Breit, Bernhard |
|
utue.personen.roh |
Jung, Manfred |
|
utue.personen.roh |
Schüle, Roland |
|
dcterms.isPartOf.ZSTitelID |
Future Medicinal Chemistry |
de_DE |
dcterms.isPartOf.ZS-Issue |
13 |
de_DE |
dcterms.isPartOf.ZS-Volume |
8 |
de_DE |
utue.fakultaet |
07 Mathematisch-Naturwissenschaftliche Fakultät |
de_DE |